RxDoctor Payments Data

Edouard Aboian, MD

Vascular Surgery · New Haven, CTNPI 1588830566

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (58.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medtronic at 51.5% of the total. Reporting peaked in 2024 at $12,066 and has fallen 57.1% since, to $5,181 in 2025.

$25,327in general payments, 2019–2025

Across 116 payments — averaging $218.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$13K
  • Aidoc Medical Ltd$5K
  • Alphatec Spine, Inc$3K
  • Silk Road Medical, Inc.$1K
  • W. L. Gore & Associates, Inc.$1K
  • Boston Scientific$793
  • plus $2K from 10 others
$42,704in research payments, 2019–2025

Across 13 payments — averaging $3284.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$43K

What the payments were for

  • Consulting fees$4,55018%
  • Grants$1671%
  • Travel & lodging$14,90859%
  • Food & beverage$5,66822%
  • Education$350%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,327 in reported general payments places this provider in the 70th percentile of 82 vascular surgery providers in Connecticut.

See all vascular surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$80,737
Medicare patients
316
Services billed
474

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →